Hypertension

Mediterranean Diet Linked to Reduce Risk of Adverse Pregnancy Outcomes in Nulliparous Women

December 23, 2022

Data from the nuMoM2b study suggests greater adherence to a Mediterranean diet was associated with reductions of 37%, 28%, and 21% in odds of gestational diabetes, preeclampsia, and any adverse pregnancy outcome, respectively, among a cohort of more than 7000 nulliparous women.

Excessive Coffee Consumption Could Spell Disaster for People with Hypertension

December 21, 2022

An analysis of data from the Japanese Collaborative Cohort Study for Evaluation of Cancer Risk suggests those with grade 2-3 hypertension could be increasing their risk of cardiovascular death by consuming 2 or more cups of coffee per day.

Parkinson Disease Treatment, Bromocriptine, Could Reduce Arterial Stiffness, Blood Pressure in Pediatric T1D

December 06, 2022

Data from the BCQR-T1D study, which was funded by the National Institutes of Health, suggest use of the dopamine receptor agonist bromocriptine was associated with improved blood pressure and arterial stiffness after 4 weeks of treatment in youth with type 1 diabetes.

Many Cases of New-Onset Postpartum Hypertension Go Unnoticed for Weeks

November 15, 2022

An analysis of data from deliveries occurring at a large, urban medical center in Boston from 2016-2018 suggests more than 10% of women with no history of hypertension developed hypertension within a year after delivery.

Study Proves Feasibility of Entirely Remote Management of Hypertension, Cholesterol Disorders

November 10, 2022

A 10,000-person study provides insight into the feasibility and effectiveness of participation an entirely remote hypertension and lipid management program in a diverse health care network.

Phase 2 Data Shows Promise for Baxdrostat in Treatment-Resistant Hypertension

November 07, 2022

Phase 2 data from the BrigHTN trial suggest use of 2 mg baxdrostat was associated with significantly and substantially reduced systolic and diastolic blood pressure in patients with treatment-resistant hypertension. In a Q&A, trial investigator Deepak Bhatt, MD, MPH, provides further insight.

Pooled Data from RADIANCE Demonstrates Ability of Denervation to Lower Blood Pressure

November 06, 2022

A pooled analysis of data from the RADIANCE-HTN TRIO, RADIANCE-HTN SOLO, and RADIANCE II trials provide a comprehensive overview of the potential reductions in blood pressure possible with renal denervation.

Lockdowns, Stay-At-Home Orders May Have Hampered Hypertension Control in US Adults

November 02, 2022

An analysis comparing prepandemic blood pressure management against blood pressure management during the first months of the COVID-19 pandemic details rising blood pressure and declining blood pressure control coinciding with the implementation of lockdown and stay-at-home orders.

Nifedipine Could Help Reduce Severe Hypertension in Women with Preeclampsia

October 11, 2022

A trial of 110 women suggests use of nifedipine extended-release leading up to delivery could reduce risk of severe hypertension events among pregnant women with preeclampsia without increasing risk of adverse neonatal outcomes.

Long-Term Follow-Up Supports Renal Denervation in Resistant Hypertension

September 21, 2022

Deepak Bhatt, MD, MPH, discusses the long-term follow-up data from SYMPLICITY HTN-3 from TCT 2022 and explores the prospect of renal denervation outside of clinical trial settings.